News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,890 Results
Type
Article (8016)
Company Profile (140)
Press Release (475734)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166743)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238196)
Policy (17898)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (484)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (103)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (261)
Approvals (10359)
Artificial intelligence (316)
ASCO (159)
Autoimmune disease (204)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (107)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (504)
Cancer (3610)
Cardiovascular disease (215)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (473)
Cervical cancer (34)
Clinical research (47806)
Collaboration (1226)
Commercialization (2)
Compensation (1421)
Complete response letters (34)
COVID-19 (753)
CRISPR (63)
C-suite (728)
Cystic fibrosis (84)
Data (5572)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (338)
Diagnostics (4171)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (162)
Earnings (73379)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87553)
Executive appointments (694)
FDA (12341)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (900)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (287)
Government (940)
Grass and pollen (2)
Guidances (280)
Healthcare (9311)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (155)
Infectious disease (941)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (249)
Interviews (41)
IPO (12382)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (5)
Liver cancer (44)
Longevity (15)
Lung cancer (501)
Lymphoma (248)
Machine learning (27)
Management (3)
Manufacturing (521)
Marketing (7)
MASH (117)
Medical device (8649)
Medtech (8783)
Mergers & acquisitions (14372)
Metabolic disorders (698)
mRNA (52)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (217)
Neuropsychiatric disorders (38)
Neuroscience (1809)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (221)
Opinion (10)
Ovarian cancer (157)
Pain (170)
Pancreatic cancer (193)
Parkinson's disease (200)
Partnered (11)
Patents (464)
Patient recruitment (496)
Peanut (31)
People (41181)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15447)
Phase 2 (21348)
Phase 3 (14378)
Pipeline (6938)
Policy (18)
Postmarket research (1570)
Preclinical (6532)
Press Release (34)
Prostate cancer (188)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (565)
Real estate (3019)
Recruiting (6)
Regulatory (14755)
Reports (16)
Research institute (579)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (151)
Series B (119)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (50)
Vaccines (317)
Venture capital (17)
Weight loss (73)
Women's health (76)
Date
Today (169)
Last 7 days (473)
Last 30 days (1411)
Last 365 days (19220)
2026 (11522)
2025 (19251)
2024 (22986)
2023 (26541)
2022 (34590)
2021 (37176)
2020 (33479)
2019 (23256)
2018 (17468)
2017 (18765)
2016 (17920)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (72)
Alaska (2)
Arizona (298)
Arkansas (11)
Asia (17864)
Australia (2095)
California (11723)
Canada (3088)
China (510)
Colorado (474)
Connecticut (399)
Delaware (205)
Europe (24595)
Florida (1750)
Georgia (369)
Hawaii (3)
Idaho (46)
Illinois (691)
India (45)
Indiana (314)
Iowa (14)
Japan (395)
Kansas (99)
Kentucky (30)
Louisiana (26)
Maine (25)
Maryland (1175)
Massachusetts (7742)
Michigan (303)
Minnesota (553)
Mississippi (4)
Missouri (79)
Montana (20)
Nebraska (11)
Nevada (113)
New Hampshire (60)
New Jersey (2581)
New Mexico (12)
New York (2778)
North Carolina (1253)
North Dakota (4)
Northern California (5858)
Ohio (273)
Oklahoma (14)
Oregon (16)
Pennsylvania (2226)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4863)
Tennessee (116)
Texas (1894)
United States (38177)
Utah (354)
Vermont (1)
Virginia (151)
Washington D.C. (38)
Washington State (908)
West Virginia (1)
Wisconsin (73)
483,890 Results for "namocell inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
Bio-Techne Corporation (NASDAQ:TECH), today announced it has completed the acquisition of Namocell, Inc.
July 5, 2022
·
2 min read
Deals
BIO-TECHNE TO ACQUIRE NAMOCELL
Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Namocell, Inc.
June 22, 2022
·
4 min read
BioMidwest
NAMOCELL HIGHLIGHTED IN NATURE PUBLICATION FOR EFFICIENT SINGLE CELL CLONING OF HUMAN PLURIPOTENT STEM CELLS
Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of a single-cell cloning workflow study using the Namocell ™ Single Cell Dispenser in Nature Protocols: Efficient and safe single-cell cloning of human pluripotent stem cells using the chroman 1, emricasan, polyamines, and trans-ISRIB (CEPT) cocktail.
November 17, 2022
·
3 min read
Biotech Bay
HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases
HepaTx Corporation, Namocell Inc., and Takara Bio USA, Inc. announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like cells differentiated from adipose tissue-derived stromal cells using Namocell’s Single Cell Dispensers and Takara Bio’s SMART-seq® kits to characterize HepaTx’s novel cell therapies for liver disease.
March 12, 2021
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Business
Namocell, Takara Bio USA and HepaTx collaborate on single cell genomics analysis for cell therapy to treat late-stage liver diseases
Namocell Inc. announced that it has entered into a collaboration with Takara Bio and HepaTx to use Namocell’s Single Cell Dispensers to perform single cell isolation on HepaTx’s unique hepatocyte-like cells developed from adipose tissue-derived stromal cells, and characterize them by single cell RNA-seq using Takara Bio’s SMART-Seq technology.
February 21, 2020
·
2 min read
Press Releases
Therma Bright Inc. Completes Debt Settlements
July 30, 2026
·
3 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend
August 4, 2026
·
1 min read
Press Releases
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
August 5, 2026
·
3 min read
1 of 48,389
Next
